Cargando…
CuS@BSA-NB2 Nanoparticles for HER2-Targeted Photothermal Therapy
Breast cancer is characterized by the uncontrolled proliferation of breast epithelial cells under the action of a variety of carcinogens. Although HER2-inhibitors were currently applied for HER2-positive breast cancer patients, they didn’t work for patients with resistance to HER2-targeted anti-canc...
Autores principales: | Ying, Ming, Li, Qin, Wu, Jingbo, Jiang, Yihang, Xu, Zhourui, Ma, Mingze, Xu, Gaixia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8815789/ https://www.ncbi.nlm.nih.gov/pubmed/35126119 http://dx.doi.org/10.3389/fphar.2021.779591 |
Ejemplares similares
-
The Ultrasmall Biocompatible CuS@BSA Nanoparticle and Its Photothermal Effects
por: Wan, Xiaofang, et al.
Publicado: (2019) -
Photothermal effects of CuS-BSA nanoparticles on H22 hepatoma-bearing mice
por: Dun, Xinyu, et al.
Publicado: (2022) -
Ultrasmall CuS@BSA nanoparticles with mild photothermal conversion synergistically induce MSCs-differentiated fibroblast and improve skin regeneration
por: Xiao, Yao, et al.
Publicado: (2020) -
Fucoidan-coated CuS nanoparticles for chemo-and photothermal therapy against cancer
por: Jang, Bian, et al.
Publicado: (2018) -
Biomimetic CuS nanoparticles for radiosensitization with mild photothermal therapy and GSH-depletion
por: Zhou, Xiaoxiang, et al.
Publicado: (2022)